Form D · Manufacturing
Dawah Pharmaceuticals, Inc.
Wilmington, DE · CIK 0001738106
Offering snapshot reported Oct 15, 2019 · SEC filing
- Reported sold
- $580K Offering amount: $10M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Mar 19, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 15, 2019 | Initial | $579,998 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-351062
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| None | None | none |
Source: Form D, filed Oct 15, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Maksoud Maksoud | Executive |
Issuer details
Industry: Manufacturing (See others in industry)
Address:
251 Little Falls Drive
Wilmington, DE, 19808
Wilmington, DE, 19808